KL-6 as a serologic indicator of pneumocystis carinii pneumonia in immunocompromised hosts

Internal Medicine

Volumn 37, Issue 3, 1998, Pages 307-310

  Hamada, Hironobu ^a   Kohno, Nobuoki ^b   Yokoyama, Akihito ^b   Hirasawa, Yutaka ^b   Hiwada, Kunio ^b   Sakatani, Mitsunori ^a   Ueda, Einosuke ^a  

^a Natl Kinki Chuo Hosp Chest Dis   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hyperplastic pneumocyte; Pneumonitis

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; BETAMETHASONE; CORTICOSTEROID; COTRIMOXAZOLE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MUCIN; NIMUSTINE; PENTAMIDINE ISETHIONATE; PREDNISOLONE; PROTEIN KL6; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC VALUE; FEMALE; GLIOBLASTOMA; HUMAN; IMMUNE DEFICIENCY; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PNEUMOCYSTIS PNEUMONIA; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; STEROID THERAPY; TREATMENT OUTCOME;

EID: 0031866928     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.37.307     Document Type: Article

References (19)

1. Gallant JE, Moore RD, Chaisson RE. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med 120: 932, 1994.
2. Simone JV, Holland E, Johnson W. Fatalities during remission of childhood leukemia. Blood 39: 759, 1972.
3. Whitcomb ME, Schwarz MI, Charles MA, Larson PH. Interstitial fibrosis after Pneumocystis carinii pneumonia. Ann Intern Med 73: 761, 1970.
4. Weber WR, Askin FB, Dehner LP. Lung biopsy in Pneumocystis carinii pneumonia. A histopathologic study of typical and atypical features. Am J Clin Pathol 67: 11, 1977.
5. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 18: 203, 1988.
6. Stahel RA, Gilks WR, Lehmann H-P, Schenker T. Third international workshop on lung tumor and differentiation antigens: Overview of the results of the central data analysis. Int J Cancer Suppl 8: 6, 1994.
7. Kohno N, Inoue Y, Hamada H, et al. Difference in sero-diagnostic values among KL-6 associated mucins classified as cluster 9. Int J Cancer Suppl 8: 81, 1994.
8. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 96: 68, 1989.
9. Hamada H, Kohno N, Akiyama M, Hiwada K. Monitoring of serum KL-6 antigen in a patient with radiation pneumonia. Chest 101: 858, 1992.
10. Kohno N, Hamada H, Fujioka S, Hiwada K, Yamakido M, Akiyama M. Circulating antigen KL-6 and lactate dehydrogenase for monitoring irradiated patients with lung cancer. Chest 102: 117, 1992.
11. Kohno N, Awaya Y, Oyama T, et al. KL-6. a mucin-like glycoprotein. in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 148: 637, 1993.
12. Kobayashi J, Kitamura S. KL-6: a serum marker for interstitial pneumonia. Chest 108: 311, 1995.
13. Kobayashi J, Kitamura S, Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis. Chest 109: 1276, 1996.
14. Kitamura S, Hiwada K, Kobayashi J, et al. Use of the ED046 kit to analyze serum KL-6 in patients with pneumonitis. Nippon Kyobu Shikkan Gakkai Zasshi (Jpn J Thorac Dis) 34: 639, 1996 (Abstract in English).
15. Hamada H, Sakatani M, Ueda E. KL-6 in patients with interstitial pneumonitis. Nippon Kyobu Shikkan Gakkai Zasshi (Jpn J Thorac Dis) 34: 771, 1996 (Abstract in English).
16. Kawakami R, Kikuchi K, Kobayashi J, et al. Pneumocystis carinii pneumonia associated with high levels of serum KL-6. Nippon Kyobu Shikkan Gakkai Zasshi (Jpn J Thorac Dis) 34: 1420, 1996 (Abstract in English).
17. Kohno N, Yokoyama A, Hirasawa Y, et al. Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia. Respir Med 91: 558, 1997.
18. Inoue Y, Barker E, Daniloff E, Kohno N, Hiwada K, Newman LS. Pulmonary epithelial cell injury and alveolar-capillary permeability in berylliosis. Am J Respir Crit Care Med 156: 109, 1997.
19. Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, Hiwada K, KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 17: 501, 1997.